跳至主要内容
临床试验/NCT00833235
NCT00833235已完成不适用

A Natural History Study of Patients With Dry Eye

Allergan17 个研究点 分布在 1 个国家目标入组 284 人开始时间: 2009年2月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Allergan
入组人数
284
试验地点
17
主要终点
Percentage of Patients with Progression of Dry Eye Disease

研究概览

简要总结

This is a multi-center, prospective, controlled, observational study of the natural history of patients with dry eye disease.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
40 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Males at least 55 years old or females, at least 40 years old with perimenopausal symptoms
  • Baseline OSDI score of ≥ 13
  • Patients with mild to moderate dry eye (dry eye disease patients only; not applicable for control group)

排除标准

  • Use of any topical cyclosporine ophthalmic emulsion within 3 months of baseline
  • History of herpes keratitis or varicella zoster keratitis
  • Any history of allergic conjunctivitis
  • Temporary or permanent occlusion or cauterization of the lacrimal puncta for either eye
  • Any anterior segment surgery involving a limbal or corneal incision (cataract surgery), keratorefractive procedure (LASIK, LASEK, PRK) within 12 months of baseline, or expectation of such surgery within 2 years
  • Patients with known systemic disease
  • Any history of corneal transplant

结局指标

主要结局

Percentage of Patients with Progression of Dry Eye Disease

时间窗: Baseline, 60 Months

次要结局

  • Change from Baseline in Ocular Surface Disease Index© (OSDI©) Score(Baseline, 60 Months)
  • Percentage of Patients with an Increase in Blurred Vision(Baseline, 60 Months)
  • Change from Baseline in Schirmer's Test(Baseline, 60 Months)
  • Change from Baseline in Conjunctival Staining Score on a 6-Point Scale(Baseline, 60 Months)
  • Change from Baseline in Corneal Staining Score on a 6-Point Scale(Baseline, 60 Months)

研究者

发起方
Allergan
申办方类型
Industry
责任方
Sponsor

研究点 (17)

Loading locations...

相似试验